Blockage of macrophage-mediated PD1/ PD-L1 pathways inhibits tuberculosis relapse in mice

doi:10.3969/j. issn. 1671 -7856. 2018. 04. 009

Home > Archive>Volume 28, Issue 4, 2018 >50-58. DOI:10.3969/j. issn. 1671 -7856. 2018. 04. 009

Blockage of macrophage-mediated PD1/ PD-L1 pathways inhibits tuberculosis relapse in mice
DOI:
                        10.3969/j. issn. 1671 -7856. 2018. 04. 009
                    
CSTR:
                        [cstr]
                    
Author:
                        SUN MengmengSUN Mengmeng
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS);Key Laboratory of Human Disease Animal Models, State Administration of Traditional Chinese Medicine; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infections; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases; Tuberculosis (TB) Center, Chinese Academy of Medical Sciences, Beijing 100021, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
QIN ChuanQIN Chuan
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS);Key Laboratory of Human Disease Animal Models, State Administration of Traditional Chinese Medicine; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infections; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases; Tuberculosis (TB) Center, Chinese Academy of Medical Sciences, Beijing 100021, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
TANG JunTANG Jun
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS);Key Laboratory of Human Disease Animal Models, State Administration of Traditional Chinese Medicine; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infections; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases; Tuberculosis (TB) Center, Chinese Academy of Medical Sciences, Beijing 100021, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
ZHAN LingjunZHAN Lingjun
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS);Key Laboratory of Human Disease Animal Models, State Administration of Traditional Chinese Medicine; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infections; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases; Tuberculosis (TB) Center, Chinese Academy of Medical Sciences, Beijing 100021, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:(Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS);Key Laboratory of Human Disease Animal Models, State Administration of Traditional Chinese Medicine; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infections; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases; Tuberculosis (TB) Center, Chinese Academy of Medical Sciences, Beijing 100021, China)
Clc Number:R-33
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Objective To study the immune intervention effect and mechanism of blockage of macrophage-mediated PD1 / PD-L1 pathways with functional PD-L1(programmed cell death ligand-1,PD-L1)monoclonal antibody upon tuberculosis (TB) relapse in mice. Methods Female C57BL/6 mice were infected by tail vein injection of 106 CFU M. tuberculosis H37Rv to obtain active TB infection. Two weeks postinfection, the mice in different groups were administered isoniazid (10 mg/ kg) (group ISO) and isoniazid combined with PD-L1 monoclonal antibody (50 μg/ each) (group ISO +PD-L1) respectively, continued for four weeks to obtain latent infection. The subsequent relapse was monitored. Among the treatment groups, the TB relapse was induced by TNF-α antibody (50 ug/ each) for four weeks from the beginning of latent stage. At each scheduled time point, bacterial loads and pathological changes in the lung, spleen and liver were quantitatively analyzed, thereby, the in vivo intervention effect of PD-L1 monoclonal antibody on tuberculosis recurrence in mice was revealed. The in vitro experiment was further explored whether knock-down the expression of PD-L1 on the infected macrophages could accerlate the macrophage apoptosis. Results The bacterial burden reached 3 -4 Lg (CFU/mL), and granuloma lesions were extensive in the lung, spleen and liver in the all infected groups, which appeared as active TB stage at 2nd week postinfection. After treated, the bacterial burden of the lung, spleen and liver was decreased, and the pathological lesions alleviated in the group ISO and group ISO + PD-L1, compared with the model control group, showing significant differences, but there was no significant difference between the two treatment groups. However, compared with the group ISO, the group ISO + PD-L1 had a significantly lower bacterial load and milder pathological lesions during the relapse period. Futhermore, knock-down the expression of PD-L1 on macrophages with anti-PD-L1 or PD-L1-siRNA promoted apoptosis in macrophages. Conclusions Blockade of the PD1/ PD-L1 pathway by PD-L1 functional antibody can inhibit TB relapse in mice, and knock-down the expression of PD-L1 on macrophages or PD1/ PD-L1 pathway with functional antibody can promote apoptosis in macrophages, which together indicate that PD-L1 blockage can effectively promote isoniazid treatment of TB and remarkably inhibit the recurrence of TB in mice.

Key words:blockade with PD-L1 functional antibody; mice model of tuberculosis; tuberculosis relapse; macrophage apoptosis

Get Citation

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:November 12,2017
Revised:
Adopted:
Online: May 22,2018
Published:

Home

About this journal

Editorial Board

Info for Author

Contact Us

中文版

Get Citation

Share

Article Metrics

History

Article QR Code